|
|
|
Audited Financial Results for the year ended 31st March, 2003
| |
Unaudited results for |
Audited Results |
Consolidated Audited Results for |
| Particular |
Nine Months ended
31-12-02 |
Three Months ended
31-03-2003 |
Three months ended
31-03-02 |
Accounting year ended
31-03-2003 |
Accounting year ended
31-03-2002 |
Accounting year ended
31-03-2003 |
Accounting year ended
31-03-2002 |
| INCOME |
| 1. Sales/income from operation |
24840.52 |
7,660.46 |
7,382.40 |
32,500.98 |
30,106.04 |
38,446.33 |
30,106.10 |
| 2. Other Income |
117.65 |
160.39 |
162.29 |
278.04 |
247.98 |
308.40 |
253.81 |
| |
24,958.17 |
7.820.85 |
7,544.69 |
32,779.02 |
30,354.02 |
38,754.73 |
30,359.91 |
| 3. Total Expenditure |
| a) (Increase)/decrease in stock of finished and semi finished |
(390.57) |
(67.84) |
303.07 |
(458.41) |
(138.65) |
(458.28) |
(138.65) |
| b) Consumption of Raw/packing material |
6,738.93 |
1,843.79 |
1,629.27 |
8,582.72 |
8,157.82 |
12,003.92 |
8,157.82 |
| c) Purchase of finished goods |
3,920.39 |
1,202.19 |
918.97 |
5,122.58 |
4,012.36 |
5,064.98 |
4,012.36 |
| d) Staff Cost |
2,122.93 |
659.30 |
560.51 |
2,782.23 |
2,464.09 |
4,446.98 |
2,464.09 |
| e) Excise duty |
2,548.84 |
680.05 |
692.30 |
3,228.89 |
3,219.95 |
3,228.89 |
3,219.95 |
| f) Other Expenditure |
5,903.44 |
2,527.99 |
2,392.52 |
8,431.43 |
7,833.98 |
10,234.70 |
7,844.75 |
| 4. Interest |
405.85 |
82.13 |
79.58 |
487.98 |
454.94 |
495.10 |
449.04 |
| 5. Depreciation |
518.64 |
179.86 |
135.88 |
698.50 |
655.35 |
816.28 |
655.35 |
| 6. Profit before tax |
3,189.72 |
713.38 |
832.59 |
3,903.10 |
3,694.18 |
2,922.16 |
3,695.20 |
| 7. Provision for taxation (Including Deferred Tax) |
896.00 |
298.59 |
190.80 |
1,194.59 (**) |
597.80 (*) |
1,194.59 |
597.80 |
| 8. Profit after tax |
2,293.72 |
414.79 |
641.79 |
2,708.51 |
3,096.38 |
1,727.57 |
3,097.40 |
| 9. Minority Interest |
|
|
|
|
|
(408.00) |
|
| 10. Net Profit for the Group |
|
|
|
|
|
2,135.57 |
3,097.40 |
| 11. Paid-up Equity Share Capital |
852.99 |
852.99 |
852.99 |
852.99 |
852.99 |
852.99 |
852.99 |
| 12. Reserves & Surplus (Excluding revaluation reserve) |
|
|
|
10,965.49 |
9,016.80 |
10,387.85 |
9,012.20 |
| 13. Earning per share - not annualised (par value RS. 10/- each) Basic and Diluted |
26.89 |
4.86 |
7.52 |
31.75 |
36.30 |
25.03 |
36.31 |
| 14. Aggregate of Non-Promoter Shareholding |
| Number of Shares |
4,316,085 |
4,310,185 |
4,547,132 |
4,310,185 |
4,547,132 |
4,310,185 |
4,547,132 |
| Percentage of Shareholding |
50.60% |
50.53% |
53.31% |
50.53% |
53.31% |
50.53% |
53.31% |
|
(**) Net of excess provision of Rs. 5.41 lacs pertaining to earlier year.
(*) Net of excess provision of Rs. 20.89 lacs pertaining to earlier year
NOTES:
- The above results were reviewed by audit committee and taken on record by the Board of Directors of the Company in its meeting held on 14th June 2003.
- The Board of Directors has recommended a Dividend of Rs. 8/- (80%) per equity of Rs. 10/- each fully paid up for the year ended 31st march, 2003
- The Company has only one segment i.e. 'Pharmaceuticals.'
- Previous year figures have been regrouped and rearranged wherever consider necessary.
Note on consolidated financial results:
- The consolidated financial results include the audited results of its subsidiaries Unichem Global Holdings Limited and Niche Generics limited. but does not include the result of Unichem SA Pty Ltd which became a subsidiary in March 2003 and has its financial year from March to February.
- The consolidated financial results for 2002 -03 are not comparable with previous year as Niche Generics Limited became a subsidiary during the year 2002-03.
Place: Mumbai
Dated: June 14, 2003 |
By order of the Board
Dr. P.A. Mody
Chairman & Managing Director |
# 10 Lac = 1 Million
|
|
|
